首页> 外文期刊>Diabetes >NFATc4 and ATF3 Negatively Regulate Adiponectin Gene Expression in 3T3-L1 Adipocytes
【24h】

NFATc4 and ATF3 Negatively Regulate Adiponectin Gene Expression in 3T3-L1 Adipocytes

机译:NFATc4和ATF3负调控脂联素基因在3T3-L1脂肪细胞中的表达。

获取原文
获取原文并翻译 | 示例
       

摘要

Expression of adiponectin decreases with obesity and insulin resistance. At present, the mechanisms responsible for negatively regulating adiponectin expression in adipo-cytes are poorly understood. In this investigation, we analyzed the effects of 5' serial deletion constructs on the murine adiponectin promoter. Here, we identified the repressor region located between —472 and —313 bp of the promoter. Removal of the putative nuclear factor of activated T-cells (NFATs) binding site increased the promoter activity, and overexpression of NFATc4 reduced the promoter activity. Treatment with the calcium ionophore A23187, an activator of NFAT, reduced mRNA as well as promoter activity. The binding of NFATc4 to the promoter was associated with increased recruitment of histone deacetylase 1 and reduced acetylation of histone H3 at the promoter site. In addition, binding of activating transcription factor 3 (ATF3) to the putative activator protein-1 site located adjacent to the NFAT binding site also repressed the promoter activity. Treatment with thapsigargin, an inducer of ATF3, reduced both mRNA and promoter activity. Importantly, the binding activities of NFATc4 and ATF3, increased significantly in white adipose tissues of ob/ob and db/db mice compared with controls. Taken together, this study demonstrates for the first time that NFATc4 and ATF3 function as negative regulators of adiponectin gene expression, which may play critical roles in downregulating adiponectin expression in obesity and type 2 diabetes.
机译:脂联素的表达随肥胖和胰岛素抵抗而降低。目前,对负调控脂联素在脂肪细胞中表达的机制了解甚少。在这项调查中,我们分析了5'系列缺失构建体对小鼠脂联素启动子的影响。在这里,我们确定了位于启动子的-472和-313 bp之间的阻遏物区域。去除激活的T细胞(NFATs)结合位点的假定核因子会增加启动子活性,而NFATc4的过表达会降低启动子活性。用NFAT活化剂钙离子载体A23187进行处理,可降低mRNA以及启动子活性。 NFATc4与启动子的结合与组蛋白脱乙酰基酶1募集的增加和组蛋白H3在启动子位点的乙酰化减少有关。此外,激活转录因子3(ATF3)与位于NFAT结合位点附近的假定的激活蛋白1位点的结合也抑制了启动子的活性。 thapsigargin,ATF3的诱导剂治疗,减少了mRNA和启动子活性。重要的是,与对照组相比,ob / ob和db / db小鼠的白色脂肪组织中NFATc4和ATF3的结合活性显着增加。两者合计,这项研究首次证明NFATc4和ATF3作为脂联素基因表达的负调节剂,可能在肥胖症和2型糖尿病中下调脂联素表达起关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号